Evidence map›Paper›PMID 35807231›Full record

ArticleMolecules (Basel, Switzerland)2022

Computational Prediction and Experimental Validation of the Unique Molecular Mode of Action of Scoulerine.

Mahshad Moshari, Qian Wang, Marek Michalak, Mariusz Klobukowski, Jack Adam Tuszynski

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Mahshad MoshariDepartment of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.
Qian WangDepartment of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Marek MichalakDepartment of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Mariusz KlobukowskiDepartment of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.ORCID 0000-0001-9232-9900
Jack Adam TuszynskiDepartment of Physics, University of Alberta, Edmonton, AB T6G 2E1, Canada.ORCID 0000-0001-9976-0429
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scoulerine is a natural compound that is known to bind to tubulin and has anti-mitotic properties demonstrated in various cancer cells. Its molecular mode of action has not been precisely known. In this work, we perform computational prediction and experimental validation of the mode of action of scoulerine. Based on the existing data in the Protein Data Bank (PDB) and using homology modeling, we create human tubulin structures corresponding to both free tubulin dimers and tubulin in a microtubule. We then perform docking of the optimized structure of scoulerine and find the highest affinity binding sites located in both the free tubulin and in a microtubule. We conclude that binding in the vicinity of the colchicine binding site and near the laulimalide binding site are the most likely locations for scoulerine interacting with tubulin. Thermophoresis assays using scoulerine and tubulin in both free and polymerized form confirm these computational predictions. We conclude that scoulerine exhibits a unique property of a dual mode of action with both microtubule stabilization and tubulin polymerization inhibition, both of which have similar affinity values.

Indexed as

Antineoplastic AgentsBerberine AlkaloidsBinding SitesColchicineHumansMicrotubulesMolecular Docking SimulationTubulinTubulin ModulatorsAntineoplastic AgentsBerberine AlkaloidsColchicinediscretamineTubulinTubulin Modulatorscancer treatmentdrug discoverymicrotubulemolecular dynamic simulationprotein dockingscoulerine

Identifiers

PMID35807231
PMCPMC9268612
OpenAlexW4283271443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.